The rise in vancomycin-resistant
Adolescent
Adult
Aged
Aged, 80 and over
Ageism
Child
Child, Preschool
Enterococcus faecium
/ classification
Female
Germany
/ epidemiology
Gram-Positive Bacterial Infections
/ epidemiology
Humans
Infant
Infant, Newborn
Male
Middle Aged
Population Surveillance
Regression Analysis
Vancomycin-Resistant Enterococci
/ classification
Young Adult
ARS
Antimicrobial resistance
Enterococcus faecium
Epidemiology
Surveillance
Vancomycin resistance
Journal
Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411
Informations de publication
Date de publication:
2019
2019
Historique:
received:
13
06
2019
accepted:
09
08
2019
entrez:
6
9
2019
pubmed:
6
9
2019
medline:
26
6
2020
Statut:
epublish
Résumé
Due to limited therapeutic options, vancomycin-resistant 2012 to 2017 data from routine vancomycin susceptibility testing of 35,906 clinical From 2014 onwards the proportions of clinical The proportion of VREF is increasing in German hospitals, particularly in southern regions in Germany. Increased efforts in infection control and antibiotic stewardship activities accounting for local resistance patterns are necessary to combat the spread of VREF in Germany.
Sections du résumé
Background
Due to limited therapeutic options, vancomycin-resistant
Methods
2012 to 2017 data from routine vancomycin susceptibility testing of 35,906 clinical
Results
From 2014 onwards the proportions of clinical
Conclusion
The proportion of VREF is increasing in German hospitals, particularly in southern regions in Germany. Increased efforts in infection control and antibiotic stewardship activities accounting for local resistance patterns are necessary to combat the spread of VREF in Germany.
Identifiants
pubmed: 31485325
doi: 10.1186/s13756-019-0594-3
pii: 594
pmc: PMC6712849
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
147Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
J Hosp Infect. 2016 Nov;94(3):236-241
pubmed: 27645212
J Prev Med Hyg. 2016 Dec;57(4):E201-E204
pubmed: 28167857
Virulence. 2012 Aug 15;3(5):421-33
pubmed: 23076243
Medicine (Baltimore). 2016 Feb;95(8):e2831
pubmed: 26937912
Antimicrob Resist Infect Control. 2012 Oct 08;1(1):31
pubmed: 23039285
mBio. 2013 Aug 20;4(4):
pubmed: 23963180
Antimicrob Resist Infect Control. 2019 Jan 17;8:16
pubmed: 30675343
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1855-65
pubmed: 22210264
Infect Drug Resist. 2015 Jul 24;8:217-30
pubmed: 26244026
Antimicrob Resist Infect Control. 2015 Jun 15;4:25
pubmed: 26078865
J Med Microbiol. 2017 Dec;66(12):1782-1789
pubmed: 29116037
Dtsch Arztebl Int. 2016 Jul 1;113(26):454-9
pubmed: 27412990
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 May;61(5):522-532
pubmed: 29633033
Antimicrob Resist Infect Control. 2015 Dec 29;4:57
pubmed: 26719795
Sci Rep. 2018 Apr 19;8(1):6274
pubmed: 29674657
Expert Rev Anti Infect Ther. 2016;14(4):403-13
pubmed: 26853235
Microb Drug Resist. 2017 Jun;23(4):500-506
pubmed: 27525808
J Antimicrob Chemother. 2013 May;68 Suppl 1:i31-7
pubmed: 23587776
Clin Microbiol Infect. 2013 Jun;19(6):501-9
pubmed: 23473333
PLoS One. 2013 Aug 23;8(8):e72476
pubmed: 24009684
Nat Rev Microbiol. 2012 Mar 16;10(4):266-78
pubmed: 22421879
Euro Surveill. 2008 Nov 20;13(47):
pubmed: 19021959
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Nov;55(11-12):1370-6
pubmed: 23114435
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1288-1301
pubmed: 27573805
Antimicrob Resist Infect Control. 2018 Jun 5;7:71
pubmed: 29992016
Clin Infect Dis. 2000 Mar;30(3):466-72
pubmed: 10722429
Clin Infect Dis. 1996 Apr;22(4):663-70
pubmed: 8729206
Dtsch Arztebl Int. 2013 Sep;110(38):627-33
pubmed: 24133543
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Oct;61(10):1310-1361
pubmed: 30229318
J Infect Dis. 2007 Feb 1;195(3):339-46
pubmed: 17205471
Antimicrob Resist Infect Control. 2018 Apr 24;7:54
pubmed: 29760912
Braz J Microbiol. 2015 Jul 01;46(3):777-83
pubmed: 26413060
Indian J Med Microbiol. 2016 Jan-Mar;34(1):38-45
pubmed: 26776117
Infect Control Hosp Epidemiol. 2016 Jan;37(1):26-35
pubmed: 26434609
Dtsch Arztebl Int. 2017 Dec 15;114(50):851-857
pubmed: 29271343
Microbiology. 2009 Jun;155(Pt 6):1749-1757
pubmed: 19383684
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30782988
Public Health Rep. 2007 Mar-Apr;122(2):160-6
pubmed: 17357358
Antimicrob Resist Infect Control. 2018 Nov 14;7:133
pubmed: 30459945
Clin Infect Dis. 1998 May;26(5):1127-33
pubmed: 9597241
J Glob Antimicrob Resist. 2019 Mar;16:36-47
pubmed: 30149193